We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+39.75%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$165M
AUM Growth
+$52.7M
Cap. Flow
+$21.1M
Cap. Flow %
12.75%
Top 10 Hldgs %
78.72%
Holding
53
New
7
Increased
8
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$14.7M
2
BLUE
bluebird bio
BLUE
+$3.49M
3
SLNO
Soleno Therapeutics
SLNO
+$1.81M
4
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$1.05M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$834K

Top Sells

Rank Stock Value
1
VRML
Vermillion, Inc.
VRML
+$2.68M
2
GILD icon
Gilead Sciences
GILD
+$766K
3
EQM
EQM Midstream Partners, LP
EQM
+$605K
4
IFRX icon
InflaRx
IFRX
+$259K
5
WKHS icon
Workhorse Group
WKHS
+$32.5K

Sector Composition

Rank Sector Weight
1 Healthcare 95.54%
2 Energy 1.09%
3 Consumer Discretionary 0.16%
4 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
51
BioCryst Pharmaceuticals
BCRX
$2.37B
$95K 0.06%
20,000
– –
EQM
52
DELISTED
EQM Midstream Partners, LP
EQM
– –
-51,250
Closed -$605K
VRML
53
DELISTED
Vermillion, Inc.
VRML
– –
-3,221,933
Closed -$2.68M
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Birchview Capital held 53 positions worth $165M, up 47% from $113M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Birchview Capital deployed $21.1M of net new capital in Q2 2020, opening 7 new positions and adding to 8 existing holdings. Its largest new stake was Aspira Women's Health Inc. Common Stock: 219,816 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $766K trimmed.

  • Birchview Capital's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 219,816 shares worth $12.7M.
  • Birchview Capital added most to Soleno Therapeutics in Q2 2020, an estimated $1.81M increase.
  • Birchview Capital's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $766K.
  • Birchview Capital fully exited Vermillion, Inc. in Q2 2020, selling an estimated $2.68M.
  • Birchview Capital's ten largest holdings make up 79% of its $165M portfolio in Q2 2020.
  • Birchview Capital opened 7 new positions and closed 2 in Q2 2020.
  • Birchview Capital's portfolio value rose 47% quarter-over-quarter to $165M.

Based on Birchview Capital's 13F filing for Q2 2020, filed 10 Aug 2020.